Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [HEALTH]
2 clusters · 2 sources · 25 days · First seen · Last updated
Autoimmune disease immunotherapy research
Overview
Medical research is transitioning toward therapies that aim to reprogram or reset the immune system rather than providing continuous suppression of inflammation. In multiple sclerosis research, the focus is shifting toward immune reconstitution therapies, such as alemtuzumab and hematopoietic stem cell transplantation, which seek a durable immune reset through lymphocyte depletion and qualitative repopulation.
Further developments include experimental methods for treating severe conditions like rheumatoid arthritis and lupus. These approaches, such as CAR-T therapy adapted from oncology, aim to address underlying causes by reprogramming malfunctioning immune systems. Due to the experimental nature and potential side effects of these treatments, they are currently primarily limited to patients who have exhausted all other known treatment options.
Entities
Johns Hopkins University · NYU Langone Health · Mileydy Gonzalez · Maximilian Konig · Thomas Jefferson University
Timeline
-
[HEALTH] 2 sourcesScientists test immune system reprogramming for autoimmune diseases
Scientists are testing experimental immune system reprogramming to treat autoimmune diseases like lupus and multiple sclerosis, aiming to fix the underlying cause rather than just suppressing symptoms.
-
[HEALTH] 2 sourcesMultiple sclerosis research shifts toward immune reconstitution therapies
New research explores shifting multiple sclerosis treatment from continuous immunosuppression toward immune reconstitution therapies that aim for a durable immune reset and antigen-specific tolerance.
Sources
ceskenoviny.cz · topky.sk